Has Victor Barnica Elvir, MD received payments from drug or device companies?

Yes. Drug and device makers reported $54,171 in general payments to Victor Barnica Elvir, MD across 108 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Victor Barnica Elvir, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Victor Barnica Elvir, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Victor Barnica Elvir, MD

Colon & Rectal Surgery · Cypress, TXNPI 1881973873

Payments from drug & device makers

What this record shows

This record is dominated by education: $45,000 of the $54,171 with a category attached, or 83.1%. Intuitive Surgical accounts for 95.0% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $29,637 and has fallen 70.0% since, to $8,880 in 2025. Among colon & rectal surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,171in general payments, 2019–2025

Across 108 payments — averaging $501.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$51K
Applied Medical Resources Corporation$863
Axonics, Inc.$389
Medtronic$346
Johnson & Johnson$310
Stryker$141
plus $667 from 18 others

What the payments were for

Travel & lodging$4,2038%
Food & beverage$4,9559%
Education$45,00083%
Gifts$140%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	56	$51,455
Applied Medical Resources Corporation	3	$863
Axonics, Inc.	4	$389
Medtronic	4	$346
Johnson & Johnson	6	$310
Stryker	1	$141
THD America, Inc.	3	$71
Avanos Medical	2	$69
Myriad Genetic Laboratories, Inc.	2	$69
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$65
Integra Lifesciences Corporation	3	$54
Shire North American Group Inc	3	$53
Pacira Pharmaceuticals Incorporated	2	$39
Merck	3	$36
Aroa Biosurgery Incorporated	2	$35
Vertex	1	$30
Smith+Nephew	2	$26
Boston Scientific	1	$22
TELA Bio, Inc.	1	$19
Coherus Oncology, Inc.	1	$18
Takeda Pharmaceuticals U.S.A., Inc.	1	$18
Acera Surgical, Inc.	1	$18
Kowa Pharmaceuticals America, Inc.	1	$15
Olympus America Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,171 in reported general payments places this provider in the 90th percentile of 200 colon & rectal surgery providers in Texas.

See all colon & rectal surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$68,141

Medicare patients

102

Services billed

340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	24	$335
Neomycin Sulfate	22	$118
Metronidazole	23	$37
Tramadol Hcl	14	$29

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Cypress

Thiru LakshmanAustin$756K
Diego Marines CopadoHouston$462K
Bidhan DasSugar Land$350K
Christopher de JesusSan Antonio$201K
Farshid AraghizadehFort Worth$181K
Jefferson HurleyIrving$163K
Erik AskenasyHouston$142K
Eric HaasHouston$140K
Robert JacobsonDallas$125K
Theodoros VoloyiannisHouston$100K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →